AARDVARK THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN AUSTRALIA IN HERO PHASE 3 TRIAL FOR PRADER-WILLI SYNDROME

Reuters · 1d ago

Please log in to view news